1
|
Shahbaznejad L, Rouhanizadeh H, Navaeifar MR, Hosseinzadeh F, Movahedi FS, Rezai MS. Clinical Characteristics and Outcomes of COVID-19 in Children in Northern Iran. Int J Pediatr 2021; 2021:5558287. [PMID: 34007286 PMCID: PMC8099525 DOI: 10.1155/2021/5558287] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 03/18/2021] [Accepted: 04/03/2021] [Indexed: 01/08/2023] Open
Abstract
OBJECTIVE Since December 2019, the coronavirus disease 2019 (COVID-19) has been spread rapidly all over the world, infecting all age groups with this novel virus. In this manuscript, we report characteristics of children with COVID-19 in Mazandaran province, northern Iran. METHOD From 12 February to 28 July 2020, medical records of 100 children diagnosed with COVID-19 admitted to the hospitals of Mazandaran province were collected. Patients' age, gender, clinical symptoms, and signs, in addition to therapeutic management and outcomes, were reported. RESULTS 57 (57%) boys and 43 girls with the mean age of 104.63 ± 79.14 months were evaluated. 20 patients (20%) were transferred to the PICU (pediatric intensive care unit), and 13 children experienced a severe form of the disease, pediatric inflammatory multisystem syndrome (PIMS). The mean duration of hospitalization was 5.3 ± 4.7 days. Fever (81%), respiratory (79%), gastrointestinal (47%), and neurologic complaints (29%) were experienced by the patients in addition to skin rash (14%). Sixty-two patients needed supplemental oxygen, and 6 of them underwent endotracheal intubation. Leukopenia was reported in 7, anemia in 24, and thrombocytopenia in 12 patients. 4 patients with underlying diseases including chronic renal failure, Down syndrome with cerebral palsy, and morbid obesity died. CONCLUSION COVID-19 can cause symptoms in children in two stages. In the first week, upper and lower respiratory symptoms can occur which has lower severity and prevalence compared to adults. But after 2-3 weeks following infection, symptoms of MIS-C or multisystem involvement can occur and COVID-19 should be considered. The most common indication for admission is fever, rash, and respiratory problems.
Collapse
Affiliation(s)
- Leila Shahbaznejad
- Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | - Hamed Rouhanizadeh
- Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | - Mohammad Reza Navaeifar
- Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | - Fatemeh Hosseinzadeh
- Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | - Faeze Sadat Movahedi
- Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
| | - Mohammad Sadegh Rezai
- Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
| |
Collapse
|
5
|
Afshar P, Larijani LV, Rouhanizadeh H. A comparison of conventional rapid methods in diagnosis of superficial and cutaneous mycoses based on KOH, Chicago sky blue 6B and calcofluor white stains. Iran J Microbiol 2018; 10:433-440. [PMID: 30873272 PMCID: PMC6414738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
BACKGROUND AND OBJECTIVES Rapid confirmation of dermatomycoses is desirable, as it allows the clinicians to initiate appropriate therapy immediately. In this study, the utility of a novel contrast stain, Chicago sky blue stain, was compared with potassium hydroxide mount and calcofluor white stain to determine the causative fungal elements in the rapid detection method. MATERIALS AND METHODS In this survey, 189 samples of suspected dermatomycosis infections were assessed in 3 incubation times of 30 minutes, 2 hours, and > 6 hours. RESULTS Positive cases were shown in Chicago sky blue 6B (55%), calcofluor white (53.4%), and potassium hydroxide (36%), with 30-minute incubation. Positive results increased in other incubation times. Sensitivity, specificity, PPV, NPV and accuracy of Chicago sky blue 6B were 97%, 100%, 100%, 96% and 98% and, for potassium hydroxide, they were 66%, 98%, 97%, 98%, 80% versus CFW, respectively. CONCLUSION This study provides evidence that the Chicago sky blue 6B stain is a simple, fast and cost-effective method.
Collapse
Affiliation(s)
- Parvaneh Afshar
- Research and Development Unit of Referral Laboratory, Mazandaran University of Medical Sciences, Sari, Iran,Corresponding author: Parvaneh Afshar, MSc, Research and Development Unit of Referral Laboratory, Mazandaran University of Medical Sciences, Sari, Iran. Tel/ Fax: +981133390353,
| | - Laleh Vahedi Larijani
- Department of Pathology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran,Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran,Corresponding author: Lale Vahedi Larijani, MD, Department of Pathology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Tel/ Fax: +981133390353,
| | - Hamed Rouhanizadeh
- Department of Pediatrics, School of Medicine and Deputy of Health Management, Mazandaran University of Medical Sciences, Sari, Iran
| |
Collapse
|
6
|
Hashemi H, Haghdoost AA, Haji-Aghajani M, Janbabaee G, Maher A, Noori Hekmat S, Javadi AM, Rahimisadegh R, Emadi S, Rajabalipour MR, Haghighi H, Dehnavieh R, Ferdosi M, Khademi G, Mehralhasani MH, Sabermahani A, Bezanjani KN, Iranpour A, RashidiNejad H, Samadani FM, Maki M, Kalantari B, farrokhyar N, Rouhanizadeh H, Falakbaz M, Allahyari H, Fathalian MT, Khajehmirzaei AR, Jannati A, Derakhshani J, Rezapour A, Eftekhari J, Khaterneshanian fam P, Kazemi M, Mohammadi M, Rastbin P, Pirhayati B, Souri E, Torabipour A, Keshvari M, Alikhani N, Salehi L, Moradi M, Aghajaniyan S, Hedayati A, Kargar M, Sharifi L, OmraniKhoo H, Poursamad A, Amrolahi boyuki N, Zarei Z, Sahraei Z, Keshavaez A, Sadeghi M, Abdollahi Sabet S, Taiari K, Koohpayehzadeh J, Moazam E, Dehghani Tafti A, Forghani Dehnavi SS, Rezaei Barownaghi M, Jafari H, Foroghifar S, Arefnejad M, Ebrahimipou H, Sedaghat M, Mehdipoor S, Mollajafari F, Forouzan R, Meskini Mood S, Sharifpour S, Adel A, Nirouand S, Ghaznavi GR, Zamanzadeh R, Etesam K, Dalili M, Jafari Siriz M, Omidifar R. A Successful implementation of an idea to a nationally approved plan: Analyzing Iran's National Health Roadmap using the Kingdon model of policymaking. Med J Islam Repub Iran 2018; 32:46. [PMID: 30159297 PMCID: PMC6108245 DOI: 10.14196/mjiri.32.46] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Indexed: 11/18/2022] Open
Abstract
Introduction: Hospital beds, human resources, and medical equipment are the costliest elements in the health system and play an essential role at the time of treatment. In this paper, different phases of the NEDA 2026 project and its methodological approach were presented and its formulation process was analysed using the Kingdon model of policymaking. Methods: Iran Health Roadmap (NEDA 2026) project started in March 2016 and ended in March 2017. The main components of this project were hospital beds, clinical human resources, specialist personnel, capital medical equipment, laboratory facilities, emergency services, and service delivery model. Kingdon model of policymaking was used to evaluate NEDA 2026 development and implementation. In this study, all activities to accomplish each step in the Kingdon model was described. Results: The followings were done to accomplish the goals of each step: collecting experts' viewpoint (problem identification and definition), systematic review of the literature, analysis of previous experiences, stakeholder analysis, economic analysis, and feasibility study (solution appropriateness analysis), three-round Delphi survey (policy survey and scrutinization), and intersectoral and interasectoral agreement (policy legislation). Conclusion: In the provision of an efficient health service, various components affect each other and the desired outcome, so they need to be considered as parts of an integrated system in developing a roadmap for the health system. Thus, this study demonstrated the cooperation process at different levels of Iran's health system to formulate a roadmap to provide the necessary resources for the health sector for the next 10 years and to ensure its feasibility using the Kingdon policy framework.
Collapse
Affiliation(s)
- Hassan Hashemi
- Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - Ali Akbar Haghdoost
- Modeling in Health Research Center, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | | | - Ghasem Janbabaee
- Department of Hematology-Oncology, Gastrointestinal Cancer Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| | - Ali Maher
- Department of Health Policy, School of Medical Education, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Somayeh Noori Hekmat
- Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Amir M. Javadi
- Executive director, Iranian healthcare information Observatory, Researcher of Noor Ophthalmology Research Center, Tehran, Iran
| | - Rohaneh Rahimisadegh
- Research Center for Health Services Management, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Samira Emadi
- Research Center for Health Services Management, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Mahamad Reza Rajabalipour
- Supervisor of Public Health Department in School of Public Health in Bam University of Medical Sciences, Bam, Iran
| | - Hajar Haghighi
- Research Center for Health Services Management, Future Studies Research Center in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Reza Dehnavieh
- Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman,
Iran
| | - Masoud Ferdosi
- Health Management and Economics Research Center (HMERC), Isfahan University of Medical Sciences, Isfahan, Iran
| | - Gholamreza Khademi
- Assistant Director of Medical Accident and Emergency Management Center, Kerman University of Medical Sciences, Kerman, Iran
| | - Mohammad Hossein Mehralhasani
- Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Asma Sabermahani
- Research Center for Health Services Management, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Kaveh Nouhi Bezanjani
- Master of Public Administration, Research Center for Health Services Management, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Abedin Iranpour
- HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Hamidreza RashidiNejad
- Research Center for Modeling in Health, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Fatemeh Moeen Samadani
- Department of Statistics, Deputy of Curative Affaire, Kerman University of Medical Sciences, Kerman, Iran
| | - Maryam Maki
- Department of Environmental Health, School of public Health, Kerman University of Medical Sciences, Kerman, Iran
| | - Behzad Kalantari
- MD, Department of Planning, Deputy of Curative Affaire, MOHME, Tehran, Iran
| | - Nahid farrokhyar
- Department of Planning, Deputy of Curative Affaire, MOHME, Tehran, Iran
| | - Hamed Rouhanizadeh
- Department of Pediatrics, Mazandaran University of Medical Sciences, Sari, Iran
| | - Monireh Falakbaz
- Department of Statistics, Deputy of Curative Affaire, Guilan University of Medical Sciences, Rasht, Iran
| | | | - Mohammad Taghi Fathalian
- Management of Diseases, Diagnosis & Treatment Center, Semnan University of Medical Sciences, Semnan, Iran
| | - Ali Reza Khajehmirzaei
- MD, vice-chancellery of treatment, Shahroud University of Medical Sciences, Shahroud, Iran
| | - Ali Jannati
- Iranian Center of Excellence in Health Management (IceHM), School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Javad Derakhshani
- Health Information Officer, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Ali Rezapour
- Human Resources. Head of Hospital Administration and Clinical Services Excellence. Ardabil University of Medical Sciences, Ardabil, Iran
| | - Jamal Eftekhari
- Department of clinical affairs, Urmia university of medical sciences, Urmia, Iran
| | - Parisa Khaterneshanian fam
- Head of hospital administration and clinical services excellence. Treatment dept. Faculty of medical sciences and health services, Maragheh. Maragheh, Iran
| | - Mahmoud Kazemi
- Department of Statistics, Deputy of Curative Affaire, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Mohsen Mohammadi
- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Payam Rastbin
- Department of Statistics, Deputy of Curative Affaire, medical university of Kurdestan, Iran
| | - Bahareh Pirhayati
- Expert Statistics, Unit of Statistics, Ilam University of Medical Science,
Ilam, Iran
| | - Elahe Souri
- Deputy of Curative Affaire, Hamadan University of Medical Science, Hamadan, Iran
| | - Amin Torabipour
- Department of Health Services Management, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Mohammad Keshvari
- Department of Health Services Management, School of Medical Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
| | - Najmeh Alikhani
- Faculty of Management and Economics, Science and Research Branch, Islamic Azad University, Tehran, Iran
| | - Lobat Salehi
- Head of The Policy and Strategic Planning Division, the Chancellor and Chief Executive Office, Shiraz University of Medical Sciences
| | - Mohammad Moradi
- Senior expert in the policy-making and planning center of Shiraz University of Medical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
| | | | | | | | - Leila Sharifi
- Nursing Director of Bandar Abbas University of Medical Sciences, Iran
| | - Habib OmraniKhoo
- Department of Public Health, Faculty of health, Bushehr University of Medical Sciences, Bushehr, Iran
| | | | - Noraste Amrolahi boyuki
- Head of Administrative Affairs and Human Resources Department of Treatment, Alborz University of Medical Science, Alborz, Iran
| | - Zahra Zarei
- Qum University of Medical Sciences. Qum. Iran
| | - Zohre Sahraei
- Vice-Chancellor in Treatment Affairs, Qazvin University of Medical Science, Qazvin, Iran
| | - Abdollah Keshavaez
- Vice-Chancellor in Treatment Affairs, Qazvin University of Medical Science, Qazvin, Iran
| | | | - Somayae Abdollahi Sabet
- Department of Community Medicine, Faculty of Medicine Zanjan University of Medical Sciences, Zanjan, Iran
| | - Katayon Taiari
- Deputy of Curative Affaire, Saveh university of medical sciences, Saveh. Iran
| | - Jalil Koohpayehzadeh
- Preventive Medicine & Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Elham Moazam
- Cancer Prevention Research Center, Isfahan University of Medical Science, Iran
| | | | | | | | - Hossein Jafari
- Department of Statistics, Deputy of Curative Affaire, Rafsanjan University of Medical Sciences, Rafsanjan,
Iran
| | - Somayeh Foroghifar
- Department of Statistics, Deputy of Curative Affaire, Bam University of Medical Sciences, Kerman, Iran
| | - Masoud Arefnejad
- Department of Statistics, Deputy of Curative Affaire, Zabol University of Medical Sciences, Zabol, Iran
| | - Hossein Ebrahimipou
- Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mojtaba Sedaghat
- Department of Community Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - Saeedeh Mehdipoor
- Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Fariba Mollajafari
- Vice- Chancellor’s Office in Treatment Affairs, Health Economy, Standard and Health Technology Office, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Reza Forouzan
- Deputy of Curative Affaire, Sabzevar University of Medical Sciences, Sabzevar, Iran
| | - Saeed Meskini Mood
- Deputy of Curative Affaire, Zahedan University of Medical Sciences, Zahedan, Iran
| | | | - Amin Adel
- Department of management sciences and health economics, school of Health, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Shabnam Nirouand
- Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Gholam Reza Ghaznavi
- Department of Statistics, Deputy of Curative Affaire, Jiroft University of Medical Sciences, Jiroft, Iran
| | - Reza Zamanzadeh
- North Khorasan University of Medical Sciences, Bojnurd, Iran
| | - Khatereh Etesam
- The Coordination Office for Insurance, Tariffs and Standards, Birjand University of Medical Sciences, Birjand, Iran
| | - Mahdieh Dalili
- The Coordination Office for Insurance, Tariffs and Standards, Kerman University of Medical Sciences, Kerman, Iran
| | | | | |
Collapse
|
7
|
Abbaskhanian A, Zamanfar D, Afshar P, Asadpoor E, Rouhanizadeh H, Jafarnia A, Shokzadeh M. Incidence of Neonatal Hyperphenylalaninemia Based on High-performance Liquid Chromatography Confirmatory Technique in Mazandaran Province, Northern Iran (2007-2015). Int J Prev Med 2017; 8:93. [PMID: 29184644 PMCID: PMC5686926 DOI: 10.4103/ijpvm.ijpvm_24_17] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2017] [Accepted: 07/31/2017] [Indexed: 11/22/2022] Open
Abstract
Background: Classic phenylketonuria (PKU) is a metabolic disorder. The purpose of this study was to assess epidemiological factors of PKU phenotypes in a neonatal screening program for Mazandaran, Iran. Methods: In this descriptive-retrospective study from 2007 to 2015, neonates PKU level was conducted by phenylalanine level based on a biochemical technique by ELISA and then by confirmatory methods high performance liquid chromatography. Results: Of the 407,244 screened newborns (48.7% girls and 51.3% boys), 14 girls and 13 boys were diagnosed definitely from 465 suspicious cases of PKU. The incidence of PKU was 0.66 in 10,000, which was noted in different severity (severe PKU - 1:67,874, mild PKU - 1:45,249, and HPA - 1:33,937). In addition, we did not detect any cases of nonclassic PKU. Conclusions: Although the consanguineous marriage pattern is a major cause of hyperphenylalaninemia (HPA) particularly in Iranian, there was no significant difference between groups in this study. Now, screening should be executed for all of the family that they have the familial history of PKU in Iran. According to varies actual of prevalence and incidence rate of PKU reported a real patient and taking PKU with mild PKU and HPA, it is recommended, the will provide the PKU reports based on the severity of the disease.
Collapse
Affiliation(s)
- Ali Abbaskhanian
- Department of Pediatrics, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.,Clinical Research Development Unit of Bou Ali-Sina Hospital, Mazandaran University of Medical Sciences, Sari, Iran
| | - Daniel Zamanfar
- Department of Pediatrics, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.,Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran
| | - Parvaneh Afshar
- Research and Development Unit of Referral Laboratory, Deputy of Health Management, Mazandaran University of Medical Sciences, Sari, Iran
| | - Einollah Asadpoor
- Deputy of Health, Mazandaran University of Medical Sciences, Sari, Iran
| | - Hamed Rouhanizadeh
- Department of Pediatrics, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.,Deputy of Health Management, Mazandaran University of Medical Sciences, Sari, Iran
| | - Ali Jafarnia
- Deputy of Health, Babol University of Medical Sciences, Babol, Iran
| | - Mohammad Shokzadeh
- Department of Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
| |
Collapse
|